Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcription Factors | 7 | 2025 | 2738 | 2.050 |
Why?
|
| Intrinsically Disordered Proteins | 3 | 2025 | 46 | 1.700 |
Why?
|
| Transcriptional Elongation Factors | 2 | 2023 | 30 | 1.540 |
Why?
|
| G1 Phase | 1 | 2024 | 67 | 0.850 |
Why?
|
| Transcription Elongation, Genetic | 1 | 2021 | 14 | 0.740 |
Why?
|
| RNA Polymerase II | 1 | 2021 | 102 | 0.720 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2024 | 625 | 0.700 |
Why?
|
| Trans-Activators | 1 | 2024 | 840 | 0.680 |
Why?
|
| Chromatin | 3 | 2024 | 617 | 0.650 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2025 | 628 | 0.570 |
Why?
|
| Proteins | 1 | 2023 | 1101 | 0.540 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 622 | 0.530 |
Why?
|
| Chromatin Assembly and Disassembly | 3 | 2024 | 124 | 0.450 |
Why?
|
| Leukemia | 1 | 2016 | 379 | 0.400 |
Why?
|
| Precision Medicine | 1 | 2016 | 357 | 0.400 |
Why?
|
| Neoplasms | 2 | 2024 | 3038 | 0.310 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2021 | 149 | 0.300 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2024 | 567 | 0.280 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2025 | 322 | 0.270 |
Why?
|
| Models, Molecular | 2 | 2021 | 1148 | 0.240 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2025 | 37 | 0.240 |
Why?
|
| Nuclear Proteins | 2 | 2025 | 1351 | 0.240 |
Why?
|
| DNA-Binding Proteins | 2 | 2025 | 2178 | 0.230 |
Why?
|
| beta Catenin | 1 | 2025 | 232 | 0.210 |
Why?
|
| HIV Infections | 1 | 2016 | 2075 | 0.210 |
Why?
|
| Ecosystem | 2 | 2021 | 110 | 0.210 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2024 | 171 | 0.210 |
Why?
|
| Elongin | 1 | 2023 | 2 | 0.210 |
Why?
|
| Leukopenia | 1 | 2023 | 48 | 0.200 |
Why?
|
| Protein Interaction Maps | 1 | 2021 | 91 | 0.180 |
Why?
|
| Protein Binding | 2 | 2025 | 1859 | 0.180 |
Why?
|
| Cell Cycle | 1 | 2024 | 628 | 0.180 |
Why?
|
| DNA | 2 | 2024 | 1682 | 0.170 |
Why?
|
| Protein Domains | 1 | 2021 | 260 | 0.170 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2018 | 21 | 0.150 |
Why?
|
| Histone Code | 1 | 2018 | 53 | 0.140 |
Why?
|
| Peptide Hydrolases | 1 | 2018 | 149 | 0.140 |
Why?
|
| Genes, Dominant | 1 | 2017 | 253 | 0.130 |
Why?
|
| Gene Expression | 1 | 2021 | 1621 | 0.130 |
Why?
|
| Animals | 5 | 2024 | 36557 | 0.130 |
Why?
|
| Contraindications | 1 | 2016 | 79 | 0.130 |
Why?
|
| DNA Helicases | 1 | 2017 | 254 | 0.130 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2016 | 75 | 0.120 |
Why?
|
| Mutation | 2 | 2021 | 6338 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2018 | 393 | 0.120 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 176 | 0.120 |
Why?
|
| Small Molecule Libraries | 1 | 2016 | 138 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2024 | 1853 | 0.110 |
Why?
|
| Humans | 9 | 2025 | 134156 | 0.110 |
Why?
|
| DNA Repair | 1 | 2018 | 635 | 0.110 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 3798 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2023 | 2669 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 407 | 0.100 |
Why?
|
| Environmental Monitoring | 2 | 2021 | 91 | 0.090 |
Why?
|
| Benzoxazoles | 1 | 2006 | 11 | 0.060 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2025 | 31 | 0.060 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2025 | 52 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2025 | 459 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2025 | 825 | 0.050 |
Why?
|
| Binding Sites | 1 | 2025 | 1384 | 0.050 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2021 | 18 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2023 | 336 | 0.040 |
Why?
|
| Environmental Biomarkers | 1 | 2020 | 1 | 0.040 |
Why?
|
| Biodiversity | 1 | 2021 | 89 | 0.040 |
Why?
|
| Archaea | 1 | 2020 | 13 | 0.040 |
Why?
|
| Fresh Water | 1 | 2020 | 22 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2023 | 1433 | 0.040 |
Why?
|
| Polycomb-Group Proteins | 1 | 2017 | 22 | 0.040 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2017 | 36 | 0.040 |
Why?
|
| Culture Media | 1 | 2017 | 184 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 2017 | 217 | 0.030 |
Why?
|
| Epigenomics | 1 | 2017 | 196 | 0.030 |
Why?
|
| Heterozygote | 1 | 2017 | 728 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 2045 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 426 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 2578 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 1492 | 0.030 |
Why?
|
| Mice | 2 | 2023 | 19055 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2017 | 947 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2025 | 4934 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 2539 | 0.020 |
Why?
|
| Genotype | 1 | 2017 | 2814 | 0.020 |
Why?
|
| Mycobacterium kansasii | 1 | 2006 | 2 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2006 | 90 | 0.020 |
Why?
|
| Isoniazid | 1 | 2006 | 67 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2006 | 611 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2006 | 834 | 0.010 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2006 | 408 | 0.010 |
Why?
|
| Cell Line | 1 | 2006 | 2864 | 0.010 |
Why?
|